Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 2

Sponsor Class

OTHER 93INDUSTRY 29NIH 24OTHER_GOV 10UNKNOWN 2NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Breast Neoplasms 33Esophageal Neoplasms 14Stomach Neoplasms 11Rectal Neoplasms 9Carcinoma, Non-Small-Cell Lung 9Triple Negative Breast Neoplasms 8Colorectal Neoplasms 8Small Cell Lung Carcinoma 7Lung Neoplasms 7Squamous Cell Carcinoma of Head and Neck 6Neoplasm Metastasis 6Brain Neoplasms 6Neoplasms 5Esophageal Squamous Cell Carcinoma 5Recurrence 3Nasopharyngeal Carcinoma 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, Extranodal NK-T-Cell 3Lymphoma 3Leukemia, Myeloid, Acute 3Hormone Receptor Positive Advanced Breast Cancer 3Head and Neck Neoplasms 3HER2-positive Breast Cancer 3Colonic Neoplasms 3Uterine Cervical Neoplasms 2Sarcoma 2Radiation Injuries 2Papillomavirus Infections 2Carcinoma, Small Cell 2Carcinoma, Hepatocellular 2

Interventions

endostar protein 1camrelizumab 1apatinib 1Gemcitabine 1Endostatins 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × UNKNOWN × Sarcoma × Clear all
NCT04447274 2020-06-25

A Study of Carilizumab in Combination With Apatinib in Subjects With Unresectable UPS and ASPS

ChineseAMS

Phase 2 Unknown
20 enrolled
Sarcoma

Sarcoma

NCT01812018 2013-03-15

Endostar + GT in Pulmonary Metastases of Soft Tissue Sarcoma

ChineseAMS

Phase 2 Unknown
30 enrolled
Sarcoma

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡